Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Tenet Healthcare Corp (NYSE: THC) closed at $206.31 in the last session, down -1.76% from day before closing price of $210.0. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 0.71 million shares were traded. THC stock price reached its highest trading level at $212.04 during the session, while it also had its lowest trading level at $205.515.
Ratios:
We take a closer look at THC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.07. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 3.29 whereas as Long-Term Debt/Eq ratio is at 3.26.
Wells Fargo Upgraded its Equal Weight to Overweight on May 29, 2025, while the target price for the stock was maintained at $195.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 06 ’25 when Ramsey R. Scott sold 13,322 shares for $205.11 per share. The transaction valued at 2,732,439 led to the insider holds 0 shares of the business.
Romo Tammy sold 645 shares of THC for $132,354 on Nov 05 ’25. The Director now owns 34,866 shares after completing the transaction at $205.20 per share. On Nov 06 ’25, another insider, Ramsey R. Scott, who serves as the Officer of the company, bought 13,322 shares for $205.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 18227695616 and an Enterprise Value of 33353850880. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.14, and their Forward P/E ratio for the next fiscal year is 12.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.87 while its Price-to-Book (P/B) ratio in mrq is 4.52. Its current Enterprise Value per Revenue stands at 1.6 whereas that against EBITDA is 7.46.
Stock Price History:
The Beta on a monthly basis for THC is 1.40, which has changed by 0.5097053 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $222.82, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is 1.50%, while the 200-Day Moving Average is calculated to be 22.19%.
Shares Statistics:
According to the various share statistics, THC traded on average about 1.10M shares per day over the past 3-months and 1127740 shares per day over the past 10 days. A total of 87.87M shares are outstanding, with a floating share count of 87.23M. Insiders hold about 0.74% of the company’s shares, while institutions hold 97.02% stake in the company. Shares short for THC as of 1763078400 were 2274366 with a Short Ratio of 2.07, compared to 1760486400 on 2546243. Therefore, it implies a Short% of Shares Outstanding of 2274366 and a Short% of Float of 3.49.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 2000-03-13. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
As of right now, 19.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $4.42, with high estimates of $4.86 and low estimates of $3.82.
Analysts are recommending an EPS of between $16.33 and $15.77 for the fiscal current year, implying an average EPS of $16.11. EPS for the following year is $16.45, with 20.0 analysts recommending between $17.8 and $14.2.
Revenue Estimates
According to 17 analysts,. The current quarter’s revenue is expected to be $5.47B. It ranges from a high estimate of $5.52B to a low estimate of $5.36B. As of. The current estimate, Tenet Healthcare Corp’s year-ago sales were $5.07BFor the next quarter, 17 analysts are estimating revenue of $5.45B. There is a high estimate of $5.51B for the next quarter, whereas the lowest estimate is $5.38B.
A total of 19 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.5B, while the lowest revenue estimate was $21.06B, resulting in an average revenue estimate of $21.26B. In the same quarter a year ago, actual revenue was $20.66BBased on 19 analysts’ estimates, the company’s revenue will be $22.18B in the next fiscal year. The high estimate is $22.55B and the low estimate is $21.8B.
